Lebwohl, M., Strober, B., Langley, R.G., Okubo, Y. , Foley, P., Warren, R., Peterson, L., Cross, N., Wiegratz, S., Deherder, D. and Thaçi, D. 2024. Bimekizumab 3-year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s305. DOI:https://doi.org/10.25251/skin.8.supp.305.